Advertisement

Topics

ReNeuron Group upbeat as it progresses on all stem cell fronts

04:58 EDT 29 Jun 2017 | Proactive Investors

Stem cell therapy specialist Reneuron PLC (LON:RENE) is making good progress on all of its clinical trial candidates and also in the lab, chief executive Olav Hellebo said today. "Our therapeutic development programmes have continued to progress well during the period, the highlight being positive Phase II data from the PISCES II clinical trial of our CTX cell therapy candidate for stroke disability.“ “We are encouraged by the subsequent feedback we have received from the FDA regarding our planned US pivotal Phase III clinical trial with CTX for stroke disability.  “The unmet medical need in chronic stroke disability is enormous and we are ever closer to being able to offer a potential new therapeutic option to these patients.  "We have made significant advances with our hRPC cell therapy candidate, both in terms of progressing the ongoing US Phase I/II clinical trial in retinitis pigmentosa and obtaining FDA approval for the cryopreserved formulation of this therapeutic candidate, enabling us to expand our ophthalmology programmes into new indications.   He added the pre-clinic ExoPr0 exosome therapy candidate targeting cancer had also progressed well.  "With our stroke programme moving into Phase III clinical development over the coming months and our retinal disease programmes moving into Phase II clinical development later this year, we expect to achieve significant clinical milestones during each of the next three years." Reneuron posted a loss of £15.6mln (£11.4mln); with a cash burn over the year of £12.6mln. Cash equivalents at the year end were £53mln (2016: £65.7mln).

Original Article: ReNeuron Group upbeat as it progresses on all stem cell fronts

NEXT ARTICLE

More From BioPortfolio on "ReNeuron Group upbeat as it progresses on all stem cell fronts"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Stem Cells
Track and monitor developments in stem cell research and commercial development.  Follow the tabs above to read the latest global news, research, clinical trials on stem cells and follow companies active in the stem cell industry.  BioPort...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...